China NMPA Product Recall - Magnetic therapy patch

Henan Tianzhongtang Biotechnology Co., Ltd. initiated a voluntary Level III recall of its magnetic therapy patches, as announced by the National Medical Products Administration (NMPA) on November 24, 2020. The recall, formally reported on November 13, 2020, through the Henan Provincial Drug Administration, was prompted by a critical non-compliance issue. The primary violation involved the product's magnetic core, which failed to meet established magnetic field strength regulations. The affected product is identified by Batch Number 20200801, with 50 boxes of the 13cm×17cm magnetic therapy patches impacted. Under the regulatory oversight of the NMPA and local drug administration, the company implemented several required actions. All business departments and operators were instructed to immediately cease sales of the non-compliant batch. Consumers who had purchased but not yet used the patches were to be notified to discontinue use without delay. Furthermore, all remaining products held by operators were mandated to be returned to Henan Tianzhongtang Biotechnology Co., Ltd. for proper disposal. This ensures the removal of potentially substandard medical devices from circulation, upholding product safety standards.